AI-Powered Fall Risk Prediction in Nursing Care
Launched by INONU UNIVERSITY · May 30, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new system that uses advanced technology to predict the risk of falls in patients. The goal is to create a method that can assess fall risk more effectively than traditional methods. By using machine learning and computer vision, this system aims to provide real-time monitoring and personalized evaluations of patients' movements. This could help keep patients safer and reduce the chances of complications from falls in healthcare settings.
To be eligible for this trial, participants need to be 18 years or older, able to read and write in Turkish, and able to walk with or without assistance. Participants will undergo a walking assessment where their movements will be recorded using a camera and a device that tracks their motion. This information will help researchers develop a reliable system that can quickly assess fall risk based on how a person walks. If you or a loved one meet these criteria and are interested in participating, you'll be contributing to important research that could improve patient safety in hospitals and clinics.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • Accepting voluntary participation in the study
- • Be able to read and write Turkish
- • Being able to walk with or without support
- Exclusion Criteria:
- • Not being able to speak or understand Turkish adequately
- • Being intubated.
- • To be identified.
- • Being immobile
- • Having a mental disability.
About Inonu University
Inonu University is a prominent academic institution located in Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative research initiatives aimed at improving patient care and advancing scientific knowledge. With a strong commitment to ethical standards and regulatory compliance, Inonu University collaborates with various stakeholders, including healthcare professionals and industry partners, to conduct rigorous clinical trials that contribute to the development of new therapies and treatment modalities. Through its research endeavors, the university strives to enhance healthcare outcomes and foster a culture of inquiry within the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Malatya, Battalgazi, Turkey
Patients applied
Trial Officials
Gürkan Özden, Assistant Professor
Study Director
Inonu University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported